42 related articles for article (PubMed ID: 24302545)
21. Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
Chen BB; Murakami T; Shih TT; Sakamoto M; Matsui O; Choi BI; Kim MJ; Lee JM; Yang RJ; Zeng MS; Chen RC; Liang JD
Liver Cancer; 2015 Dec; 4(4):215-27. PubMed ID: 26734577
[TBL] [Abstract][Full Text] [Related]
22. MR Imaging Biomarkers in Oncology Clinical Trials.
Abramson RG; Arlinghaus LR; Dula AN; Quarles CC; Stokes AM; Weis JA; Whisenant JG; Chekmenev EY; Zhukov I; Williams JM; Yankeelov TE
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):11-29. PubMed ID: 26613873
[TBL] [Abstract][Full Text] [Related]
23. Prognostication and response assessment in liver and pancreatic tumors: The new imaging.
De Robertis R; Tinazzi Martini P; Demozzi E; Puntel G; Ortolani S; Cingarlini S; Ruzzenente A; Guglielmi A; Tortora G; Bassi C; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2015 Jun; 21(22):6794-808. PubMed ID: 26078555
[TBL] [Abstract][Full Text] [Related]
24. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
[TBL] [Abstract][Full Text] [Related]
26. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma.
Goshima S; Kanematsu M; Noda Y; Kondo H; Watanabe H; Bae KT
AJR Am J Roentgenol; 2015 May; 204(5):W543-9. PubMed ID: 25905960
[TBL] [Abstract][Full Text] [Related]
27. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
28. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment.
Yuan Z; Zhang J; Yang H; Ye XD; Xu LC; Li WT
J Vasc Interv Radiol; 2016 Jan; 27(1):20-30; quiz 31. PubMed ID: 26621785
[TBL] [Abstract][Full Text] [Related]
30. Radiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imaging (Review).
Ye XD; Yuan Z; Zhang J; Yuan Z
Oncol Rep; 2017 Mar; 37(3):1337-1346. PubMed ID: 28184942
[TBL] [Abstract][Full Text] [Related]
31. Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma?
Cao Y; Cuneo KC; Evans J; Ten Haken RK; Chang DT; Lawrence TS
Cancer J; 2023 Jul-Aug 01; 29(4):238-242. PubMed ID: 37471615
[TBL] [Abstract][Full Text] [Related]
32. Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy.
Kim KA; Park MS; Ji HJ; Park JY; Han KH; Kim MJ; Kim KW
J Magn Reson Imaging; 2014 Feb; 39(2):286-92. PubMed ID: 24302545
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
